Madeleine Cunningham
Gründer bei Moleculera Labs, Inc.
Profil
Madeleine Cunningham is the founder of Moleculera Labs, Inc. which was founded in 2011.
She held the title of Chief Scientific Officer at the time of founding.
Currently, she holds the position of Director-Immunology Training Program at the University of Oklahoma Health Sciences Center and the position of Director at the National Institutes of Allergy & Infectious Diseases.
Aktive Positionen von Madeleine Cunningham
| Unternehmen | Position | Beginn |
|---|---|---|
Moleculera Labs, Inc.
 Moleculera Labs, Inc. Medical/Nursing ServicesHealth Services Moleculera Labs, Inc. provides clinical testing services for children and families suspected of suffering from Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infections (PANDAS)/Pediatric Acute-onset Neuropsychiatric Syndrome (PANS), which are treatable neurologic conditions that may be associated with motor tics, obsessive compulsive disorders, and sometimes Autism Spectrum Disorders. It offers its services to the physician as an aid in their diagnosis of PANDAS/PANS/Childhood Acute Neuropsychiatric Symptoms in parts of the United States. The company was founded by Madeleine Cunningham and Craig Shimasaki in 2011 and is headquartered in Oklahoma City, OK. | Gründer | 01.01.2011 |
University of Oklahoma Health Sciences Center
 University of Oklahoma Health Sciences Center Other Consumer ServicesConsumer Services Part of University of Oklahoma, University of Oklahoma Health Sciences Center functions as a College/University. The company is based in Oklahoma City, OK. | Corporate Officer/Principal | - |
National Institutes of Allergy & Infectious Diseases
 National Institutes of Allergy & Infectious Diseases General GovernmentGovernment National Institutes of Allergy & Infectious Diseases develops therapies, vaccines and diagnostic tests for infectious diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Moleculera Labs, Inc.
Moleculera Labs, Inc. Medical/Nursing ServicesHealth Services Moleculera Labs, Inc. provides clinical testing services for children and families suspected of suffering from Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infections (PANDAS)/Pediatric Acute-onset Neuropsychiatric Syndrome (PANS), which are treatable neurologic conditions that may be associated with motor tics, obsessive compulsive disorders, and sometimes Autism Spectrum Disorders. It offers its services to the physician as an aid in their diagnosis of PANDAS/PANS/Childhood Acute Neuropsychiatric Symptoms in parts of the United States. The company was founded by Madeleine Cunningham and Craig Shimasaki in 2011 and is headquartered in Oklahoma City, OK. | Health Services |
University of Oklahoma Health Sciences Center
University of Oklahoma Health Sciences Center Other Consumer ServicesConsumer Services Part of University of Oklahoma, University of Oklahoma Health Sciences Center functions as a College/University. The company is based in Oklahoma City, OK. | Consumer Services |
National Institutes of Allergy & Infectious Diseases
National Institutes of Allergy & Infectious Diseases General GovernmentGovernment National Institutes of Allergy & Infectious Diseases develops therapies, vaccines and diagnostic tests for infectious diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
